MITOMYCIN FOR INJECTION USP POWDER FOR SOLUTION كندا - الإنجليزية - Health Canada

mitomycin for injection usp powder for solution

accord healthcare inc - mitomycin - powder for solution - 20mg - mitomycin 20mg - antineoplastic agents

MITOMYCIN FOR INJECTION, USP POWDER FOR SOLUTION كندا - الإنجليزية - Health Canada

mitomycin for injection, usp powder for solution

hikma canada limited - mitomycin - powder for solution - 20mg - mitomycin 20mg

MITOMYCIN FOR INJECTION USP POWDER FOR SOLUTION كندا - الإنجليزية - Health Canada

mitomycin for injection usp powder for solution

pfizer canada ulc - mitomycin - powder for solution - 20mg - mitomycin 20mg - antineoplastic agents

MITOMYCIN FOR INJECTION USP POWDER FOR SOLUTION كندا - الإنجليزية - Health Canada

mitomycin for injection usp powder for solution

pfizer canada ulc - mitomycin - powder for solution - 5mg - mitomycin 5mg - antineoplastic agents

MITOCIN mitomycin 20 mg powder for injection vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

mitocin mitomycin 20 mg powder for injection vial

echo therapeutics pty ltd - mitomycin, quantity: 20 mg - injection, powder for - excipient ingredients: nitrogen; mannitol; hydrochloric acid; sodium hydroxide - mitomycin is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.

MITOMYCIN injection, powder, lyophilized, for solution الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mitomycin injection, powder, lyophilized, for solution

eugia us llc - mitomycin (unii: 50sg953sk6) (mitomycin - unii:50sg953sk6) - mitomycin for injection, usp is not recommended as single-agent, primary therapy. it has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. mitomycin is not recommended to replace appropriate surgery and/or radiotherapy. mitomycin is contraindicated in patients who have demonstrated a hypersensitive or idiosyncratic reaction to it in the past. mitomycin is contraindicated in patients with thrombocytopenia, coagulation disorder, or an increase in bleeding tendency due to other causes.

Mitomycine-C Kyowa 20 mg i.vesic. sol. (pwdr.) vial بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mitomycine-c kyowa 20 mg i.vesic. sol. (pwdr.) vial

takeda belgium sa-nv - mitomycin 20 mg - powder for intravesical solution - 20 mg - mitomycin 20 mg - mitomycin